Unrest
London, United KingdomInvestor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bambusa Therapeutics | Nov 17, 2025 | Biotechnology, Bispecific Antibodies, Immunological and Inflammatory Disorders, Immunology, Inflammation, Inflammatory and Immunological Therapeutics | Early stage | - |  Boston, Massachusetts |
| Bactolife | Aug 8, 2023 | Animal Health, Antimicrobial Resistance, Binding Protein Technology, Bioindustrial, Food and Feed Industry, Gut Microbiome, Gut Microbiome Health, Precision Gut Microbiome | Early stage | 30000000 EUR |  Copenhagen, |
| Bactolife | Aug 8, 2023 | Animal Health, Antimicrobial Resistance, Bioindustrial, Gastrointestinal Infections, Gut Microbiome, Precision Gut Microbiome | Early stage | 30000000 EUR | Copenhagen |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.